Ron Cohen, Acorda Therapeutics president & CEO
Letters to the Editor: Don't expect a correlation between an individual drug's development cost and price
Endpoints News recently reported on a new paper in JAMA that purports to show that there is no correlation between the price of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
